Hemorrhagic Disorders D006474

Diseases [C] » Hemic and Lymphatic Diseases [C15] » Hematologic Diseases » Hemorrhagic Disorders

Description

Spontaneous or near spontaneous bleeding caused by a defect in clotting mechanisms (BLOOD COAGULATION DISORDERS) or another abnormality causing a structural flaw in the blood vessels (HEMOSTATIC DISORDERS).   MeSH

Hierarchy View

Subtype Terms (21)

Afibrinogenemia
2 approved drugs

Bernard-Soulier Syndrome
 

Disseminated Intravascular Coagulation
10 drugs (7 approved, 3 experimental)

Factor V Deficiency
 

Factor VII Deficiency
6 drugs (3 approved, 3 experimental)

Factor X Deficiency
1 approved drug

Factor XI Deficiency
1 approved drug

Factor XII Deficiency
 

Factor XIII Deficiency
1 approved drug

Hemophilia A
89 drugs (43 approved, 46 experimental)

Hemophilia B
43 drugs (13 approved, 30 experimental)

Hemostatic Disorders
3 drugs (1 approved, 2 experimental)

Hypoprothrombinemias
2 approved drugs

Platelet Storage Pool Deficiency
6 approved drugs

Purpura, Thrombocytopenic, Idiopathic
79 drugs (54 approved, 25 experimental)

Thrombasthenia
10 drugs (8 approved, 2 experimental)

Thrombocythemia, Essential
65 drugs (41 approved, 24 experimental)

Vitamin K Deficiency
4 drugs (2 approved, 2 experimental)

von Willebrand Diseases
16 drugs (7 approved, 9 experimental)

Waterhouse-Friderichsen Syndrome
 

Wiskott-Aldrich Syndrome
35 drugs (25 approved, 10 experimental)


Phase 4 Indicated Drugs (1)

Phase 2 Indicated Drugs (2)


Organization Involved with Phase 4 Indications (2)

Organization Involved with Phase 2 Indications (4)

Organization Involved with Phase 1 Indications (1)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.